(Senior) Medical Science Liaison - Sunbelt (US, Nashville)

Tennessee, United States

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Biotechnology, Precision MedicineIndustries

Requirements

Candidates must possess an advanced scientific or medical degree (PhD, PharmD, MD, MSN, BSN) and a fundamental understanding of molecular oncology and related patient management algorithms. A basic understanding of oncology is required, with a molecular testing background strongly preferred. Existing relationships with Key Opinion Leaders (KOLs) in oncology and familiarity with genomic laboratory-developed testing (LDT), CLIA-88’, CAP, and the Sunshine Act are necessary. Public speaking and exceptional interpersonal communication skills are essential, along with strong inter- and intradepartmental management abilities. The role requires a self-starter mindset, the ability to work under tight deadlines, and up to 50% travel. Preferred qualifications include over 1 year of MSL experience in diagnostics, biotech, or pharmaceutical industries.

Responsibilities

The Medical Science Liaison will support commercial and educational objectives by acting as a regional expert on Tempus oncology assays and technologies. Responsibilities include promoting the exchange of clinical, scientific, and technical information with regional KOLs and other oncologists, and facilitating education for a broader healthcare provider community through presentations. The role also involves providing scientific education for internal stakeholders, attending conferences to summarize key scientific findings, and continuously updating internal teams on relevant medical and scientific knowledge while sharing market intelligence.

Skills

Oncology

Genomic Testing

Clinical Data

Scientific Data

Market Intelligence

Communication Skills

Presentation Skills

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters

2015Year Founded

$894.9MTotal Funding

IPOCompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.

Ambry Genetics acquisition could pose financial risks if synergies aren't realized.

Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.

Their platform aids in personalized treatment decisions for cancer patients.

Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.

Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.

Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI

Try Jobo Free